UNSPSC 85819131: Transfusion of nonautologous white cells into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous white cells into peripheral artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30253Q1

UNSPSC 85819131 Transfusion of nonautologous white cells into peripheral artery, percutaneous approach is a Commodity code with little relevant recent state and local procurement activity. The recent solicitations tagged under this code—independent medical evaluation services for pension disability determinations, surgical benefits carve-out administration, occupational medical surveillance, specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing—span administrative healthcare services and employment-benefit program management rather than transfusion procedures or cellular therapy. State and local procurement under codes matching this UNSPSC appears minimal, and the tagged opportunities reflect a mismatch between the code's clinical procedure scope and the actual services being solicited.

Activity across the few opportunities captured involves city pension boards, county human resources divisions, state departments of transportation, county juvenile justice systems, and county health authorities soliciting medical administration, benefits coordination, and staffing services. Recent examples include the City of Phoenix Retirement Office requesting independent medical evaluation services for disability pension applications (RFP RTMRFP26001, due October 16, 2026), the City of Long Beach seeking surgical benefits carve-out management (RFP HR26753, due October 7, 2026), and the Washington State Department of Transportation soliciting occupational medical surveillance (RFP RFP20260825, due October 9, 2026). Geographic activity appears scattered across Arizona, California, and Washington, with no concentration indicating sustained demand under this code in any single state or jurisdiction. The mismatch between the code's cellular transfusion clinical descriptor and the administrative healthcare purchasing actually captured suggests this code may be misapplied in state and local cataloging systems or sees negligible direct procurement activity.